Bioinformatics, Cardiology and Development - Clinical Research Informer

How Phosphorus’ GeneCompass Preventative Genetic Test Can Help People Manage Their Health

XTalks

JULY 19, 2021

Phosphorus, a leading preventative genomics company, has developed the first comprehensive preventative genetic test for consumers. Phosphorus may be a familiar name as it was one of the first to develop an FDA-authorized at-home test for COVID-19 ; it was also the first test to have received an asymptomatic, direct-to-consumer FDA approval.

Genetics

Genetics Genome Genomics Gene

FDA grants breakthrough device designation for atrial fibrillation ECG analysis platform

Scienmag

MARCH 24, 2021

Platform developed by Tempus, Geisinger CHICAGO, March 24, 2020 — Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its ECG Analysis Platform, developed in collaboration with Geisinger.

Medicine

Medicine Development Drugs Bioinformatics

Clinical Research Informer

How Phosphorus’ GeneCompass Preventative Genetic Test Can Help People Manage Their Health

FDA grants breakthrough device designation for atrial fibrillation ECG analysis platform

Webinars

Stay Connected